Feasibility of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects With Breast Cancer

Trial Profile

Feasibility of the LUM Imaging System for Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Subjects With Breast Cancer

Recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Mar 2017

At a glance

  • Drugs LUM 015 (Primary)
  • Indications Breast cancer
  • Focus Diagnostic use; First in man
  • Sponsors Lumicell
  • Most Recent Events

    • 06 Mar 2017 Planned End Date changed from 1 Dec 2016 to 1 Jun 2016.
    • 06 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 May 2016.
    • 06 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top